EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Graft thrombosis after coronary artery bypass surgery and current practice for prevention

Lamia Harik, Roberto Perezgrovas-Olaria, Giovanni Soletti, Arnaldo Dimagli, Talal Alzghari, Kevin R An, Gianmarco Cancelli, Mario Gaudino, Sigrid Sandner

Frontiers in Cardiovascular Medicine · 08.03.2023 · 10

DOI: 10.3389/fcvm.2023.1125126 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 08.03.2023. Verfasst von Lamia Harik und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, United States. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronary artery bypass grafting (CABG) is the most frequently performed cardiac surgery worldwide. The reported incidence of graft failure ranges between 10% and 50%, depending upon the type of conduit used. Thrombosis is the predominant mechanism of early graft failure, occurring in both arterial and vein grafts. Significant advances have been made in the field of antithrombotic therapy since the introduction of aspirin, which is regarded as the cornerstone of antithrombotic therapy for prevention of graft thrombosis. Convincing evidence now exists that dual antiplatelet therapy (DAPT), consisting of aspirin and a potent oral P2Y 12 inhibitor, effectively reduces the incidence of graft failure. However, this is achieved at the expense of an increase in clinically important bleeding, underscoring the importance of balancing thrombotic risk and bleeding risk when considering antithrombotic therapy after CABG. In contrast, anticoagulant therapy has proved ineffective at reducing the occurrence of graft thrombosis, pointing to platelet aggregation as the key driver of graft thrombosis. We provide a comprehensive review of current practice for prevention of graft thrombosis and discuss potential future concepts for antithrombotic therapy including P2Y 12 inhibitor monotherapy and short-term DAPT.

Schlagwörter

Stichwörter der Autor:innen

antithromboticsaspirincoronary artery bypass graftingdual antiplatelet therapy (DAPT)graft failuregraft thrombosis

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, United States.
  • Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Harik, L., Perezgrovas-Olaria, R., Soletti, G., Dimagli, A., Alzghari, T., An, K. R., Cancelli, G., Gaudino, M., & Sandner, S. (2023). Graft thrombosis after coronary artery bypass surgery and current practice for prevention. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1125126

Vancouver

Harik L, Perezgrovas-Olaria R, Soletti G, Dimagli A, Alzghari T, An KR, et al. Graft thrombosis after coronary artery bypass surgery and current practice for prevention. Frontiers in Cardiovascular Medicine. 2023;10. doi:10.3389/fcvm.2023.1125126

BibTeX
@article{Harik2023,
  author = {Harik, Lamia and Perezgrovas-Olaria, Roberto and Soletti, Giovanni and Dimagli, Arnaldo and Alzghari, Talal and An, Kevin R and Cancelli, Gianmarco and Gaudino, Mario and Sandner, Sigrid},
  title = {Graft thrombosis after coronary artery bypass surgery and current practice for prevention},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2023},
  volume = {10},
  doi = {10.3389/fcvm.2023.1125126}
}
Kostenlos starten →